We will evaluate the changes in plasmatic EV-derived BDNF concentrations 8 weeks post rTMS treatment in PD-MCI patients relative to PD-MCI patients receiving sham rTMS treatment and those receiving no rTMS treatment. The gene discussed is BDNF; the disease is Parkinson disease.